Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...
SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various treatment options, side effects, and newer therapies.
A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...
Groundbreaking research reveals that common blood sugar medications do more than manage glucose—they are actively reshaping the biological battlefield of cancer. From the "protective" powers of ...
Calgary Herald on MSN
Ozempic and Wegovy-type generic drugs could drop prices by a third, says Calgary doctor
Albertans may see more varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago.
Nearly 17 million young Americans could be eligible for GLP-1RAs—a class of medications used to treat type 2 diabetes and obesity—including Ozempic and Wegovy. This is based on estimations from Yale ...
When diabetes causes CKD, it’s sometimes called diabetic kidney disease. Elevated blood sugar levels that result from diabetes can damage the tiny blood vessels inside your kidneys. As a result, your ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback